Arunjyoti Bio Ventures Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 5.29 | 6.21 | 6.46 |
| Operating Expense | 4.94 | 5.80 | 5.57 |
| Net Profit | -1.99 | -1.12 | -0.41 |
| Net Profit Margin | -37.62 | -18.04 | -6.35 |
| Earning Per Share | -0.11 | -0.70 | -0.35 |
| EBIDTA | -0.60 | 0.18 | 0.71 |
| Effective Tax Rate | TBA | -31.71 | -32.58 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 5.29 |
| Operating Expense | 4.94 |
| Net Profit | -1.99 |
| Net Profit Margin | -37.62 |
| Earning Per Share | -0.11 |
| EBIDTA | -0.60 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 20.43 | 1.74 | 2.97 |
| Operating Expenses Annual | 17.66 | 1.57 | 3.17 |
| Operating Profit Annual | 2.81 | 0.16 | 0.08 |
| Interest Annual | 2.09 | 0.01 | 0.00 |
| Depreciation | 2.01 | TBA | TBA |
| Net Profit Annual | -0.35 | 0.12 | 0.06 |
| Tax Annual | -0.95 | 0.04 | 0.02 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 20.43 |
| Operating Expenses Annual | 17.66 |
| Operating Profit Annual | 2.81 |
| Interest Annual | 2.09 |
| Depreciation | 2.01 |
| Net Profit Annual | -0.35 |
| Tax Annual | -0.95 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.03 | 0.01 | 0.81 |
| Cash Flow from Operations | 6.31 | -13.07 | -0.78 |
| Cash Flow from Investing | -23.29 | -19.19 | TBA |
| Cash Flow from Financing | 17.04 | 32.27 | TBA |
| Cash Flow at the End | 0.09 | 0.03 | 0.03 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.03 |
| Cash Flow from Operations | 6.31 |
| Cash Flow from Investing | -23.29 |
| Cash Flow from Financing | 17.04 |
| Cash Flow at the End | 0.09 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 13.80 | 9.77 | 2.69 |
| PBIT Margin (%) | 3.96 | 9.77 | 2.69 |
| PBT Margin (%) | 2.10 | -967.24 | 2.69 |
| Net PROFIT Margin (%) | -1.71 | 6.90 | 2.02 |
| Return On Networth / Equity (%) | TBA | 5.22 | 2.61 |
| Return On Networth /Employed (%) | TBA | 0.92 | 3.48 |
| Return On Assets (%) | -0.81 | 0.69 | 3.03 |
| Total Debt / Equity (X) | 21.57 | 7.85 | TBA |
| Asset Turnover Ratio (%) | 0.47 | 0.10 | 1.50 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 13.80 |
| PBIT Margin (%) | 3.96 |
| PBT Margin (%) | 2.10 |
| Net PROFIT Margin (%) | -1.71 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -0.81 |
| Total Debt / Equity (X) | 21.57 |
| Asset Turnover Ratio (%) | 0.47 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 40.50 | TBA | TBA |
| Total Current Assets Annual | 11.28 | 5.53 | 1.09 |
| Non Current Assets Annual | 42.71 | 30.37 | 1.00 |
| Total Shareholders Funds Annual | 1.77 | 2.12 | 2.00 |
| Total Assets Annual | 53.99 | 35.91 | 2.10 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 40.50 |
| Total Current Assets Annual | 11.28 |
| Non Current Assets Annual | 42.71 |
| Total Shareholders Funds Annual | 1.77 |
| Total Assets Annual | 53.99 |
EPS (INR)
Expected
0.19
Reported
0.19
Surprise
0.00%
Sep 2010
EPS beaten by 0.00%
